Table 5.
Relationship between PNR and clinicopathological features in patients with ovarian cancer.
| Charateristics | PNR<49.20 (N=564) | PNR≥49.20 (N=427) | P value |
|---|---|---|---|
| Age[median (range),years] | 56 (23-83) | 53 (33-80) | 0.003 |
| ≤55 | 268 | 253 | <0.001 |
| >55 | 296 | 174 | |
| Menopause | |||
| Yes | 351 | 230 | 0.008 |
| No | 213 | 197 | |
| FIGO stage | |||
| I | 35 | 20 | 0.020 |
| II | 60 | 24 | |
| III | 379 | 303 | |
| IV | 90 | 80 | |
| Family history of cancer | |||
| Yes | 186 | 141 | 0.989 |
| No | 378 | 286 | |
| Residual disease | |||
| ≤1cm | 487 | 372 | 0.723 |
| >1cm | 77 | 55 | |
| Histology | |||
| Serous | 467 | 362 | 0.405 |
| Other | 97 | 65 | |
| Grade | |||
| Well | 196 | 180 | 0.033 |
| Moderate | 145 | 88 | |
| Poor | 163 | 112 | |
| Lymph node status | |||
| Positive | 304 | 244 | 0.309 |
| Negative | 260 | 183 | |
| CA125 at diagnosis | 684.85 (213.15-1759.40) | 1105.35 (371.98-2372.88) | <0.001 |
| ≤35 U/ml | 28 | 23 | 0.766 |
| >35 U/ml | 536 | 404 | |
| Platelet (109/L) | 244.00 (193.00-312.50) | 306.00 (226.75-387.00) | <0.001 |
| Neutrophil (109/L) | 4.85 (3.83-6.30) | 3.70 (2.70-4.90) | <0.001 |
| Lymphocyte (109/L) | 1.70 (1.40-2.00) | 1.20 (0.90-1.40) | <0.001 |
| Monocyte (109/L) | 0.50 (0.40-0.70) | 0.40 (0.30-0.50) | <0.001 |
| NLR | 2.94 (2.12-4.15) | 3.27 (2.16-4.90) | 0.008 |
| LMR | 3.31 (2.33-4.50) | 2.71 (2.00-3.67) | <0.001 |
| PLR | 146.85 (109.77-190.76) | 266.67 (188.54-372.32) | <0.001 |
| SII | 712.33 (458.94-1131.67) | 944.76 (548.38-1788.06) | <0.001 |
| PNR | 31.99 (24.38-39.47) | 68.24 (58.19-88.17) | <0.001 |
The bold values represent P<0.05.